The overall level of IL-6 ( Figure 7E ) in Omicron-infected cancer patients was higher than that in Omicron-infected non-cancer-afflicted subjects, with a decreasing trend at the early stage; however, IL-6 in non-cancer-afflicted subjects was kept at a low level and had no obvious changes in the whole process of Omicron infection.
← all excerpts
Patients with advanced pancreatic and biliary cancer appear vulnerable to SARS-CoV-2 Omicron variant: An observational study during the COVID-19 outbreak in Shanghai.
1
—
—